Company: NIVFW
Filing Date: 2025-10-31
Form Type: 424B3
Source: 0001213900-25-104469
Chunk: 59

Company: NewGenIvf Group Ltd
Filing Date: 2025-10-31
Form: 424B3
Chunk 59
---
 personnel to support its operations, its business and future growth prospects could be harmed.

NewGenIvf’s success
and future growth depend largely upon the continued services of its management team and its other key employees. From time to time, there
may be changes in its executive management team or other key employees resulting from the hiring or departure of these personnel. Its
executive officers and other key employees are employed on an at-will basis, which means that these personnel could terminate their employment
with it at any time. The loss of one or more of its executive officers, or the failure by its executive team to effectively work with
its employees and lead its company, could harm its business.

In addition, to execute its
growth plan, NewGenIvf must attract and retain highly qualified personnel. Competition for these personnel is intense, especially for
experienced medical officers and scientific staffs and sales and client account management personnel. There is no guarantee NewGenIvf
will be able to attract such personnel or that competition among potential employers will not result in increased salaries or other benefits.
From time to time, NewGenIvf has experienced, and NewGenIvf expects to continue to experience, difficulty in hiring and retaining employees
with appropriate qualifications. Many of the companies with which NewGenIvf competes for experienced personnel have greater resources
than NewGenIvf has. If NewGenIvf hires employees from competitors or other companies, their former employers may attempt to assert that
these employees or NewGenIvf has breached their legal obligations, resulting in a diversion of its time and resources. In addition, prospective
and existing employees often consider the value of the equity awards they receive in connection with their contribution to the company.
If the perceived value of its equity awards declines, experiences significant volatility, or increases such that prospective employees
believe there is limited upside to the value of its equity awards, it may adversely affect its ability to recruit and retain key employees.
If NewGenIvf fails to attract new personnel or fails to retain and motivate its current personnel, its business and future growth prospects
could be harmed.

<div align='center'>34</div>

Furthermore, in order to
attract and retain key personnel and employees, the compensation amounts for NewGenIvf’s executive officers may change significantly
after consummation of the Business Combination, although there are currently no agreements in place relating to any such post Business
Combination compensation arrangements. As a result, NewGenIvf’s expenses associated with the